Immunotherapy Regenerative Medicine
Luis Padilla





| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 5.0 / 5 (4) | Puerto Vallarta, Mexico | 14+ years | — | — | — | Consejo de Salubridad General | ||
| #2 | 5.0 / 5 (2) | Cancún, Mexico | — | — | NK cell therapy, supportive stem cell therapy | Early-stage cases adding NK cell therapy to standard treatment | Expanded NK cell immunotherapy processed in its own lab, with a dedicated remission program. Protocols from UCSD and Salk research; 10,000+ patients treated in 16+ years. | — | |
| #3 | 4.0 / 5 (1) | Cancún, Mexico | 6+ years | Oncologic surgery, minimally invasive oncologic surgery, radiotherapy, chemotherapy, immunotherapy, sentinel lymph node biopsy | Minimally invasive surgery with sentinel node staging | Dedicated gynecologic tumor clinic with sentinel lymph node biopsy staging and an on-site HPV clinic for Pap smears, colposcopy and high-risk HPV DNA testing. JCI accredited. | Joint Commission International, Accreditation Canada Diamond Status Level | ||
| #4 | 4.8 / 5 | Puerto Vallarta, Mexico | 12+ years | CyberKnife, NK cell therapy, exosome treatments, high-dose vitamin C, ozone therapy | Complementary cancer care alongside conventional treatments | Offers NK cell therapy and exosome treatments specifically for cervical cancer. Combines conventional and alternative therapies with personalized care plans. | — | ||
| #5 | 5.0 / 5 | Playa del Carmen, Mexico | — | — | NK cell therapy | Early-stage cervical cancer adding NK cell therapy to standard treatment | NK cell immunotherapy for Stage I–II cases, cells activated in their own COFEPRIS-authorized lab. Protocols developed at UCSD, UCI, Salk and Burnham institutes. | — | |
| #6 | 5.0 / 5 | Playa del Carmen, Mexico | — | — | NK cell therapy, integrative approach alongside conventional cancer treatment | Stage 1–2 cases adding NK cell therapy to standard care | NK cell immunotherapy supports Stage 1–2 cases alongside standard care, backed by an on-site COFEPRIS-authorized ISO Class 5/7 lab preserving 95% cell viability. | — |